We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 3,239 results
  1. Predictive value of 18 F-FDG PET/CT versus bone marrow biopsy and aspiration in pediatric neuroblastoma

    Background

    Neuroblastoma (NB) is the most prevalent solid extracranial malignancy in children, often with bone marrow metastases (BMM) are present....

    Zhenzhen Zhao, Chao Yang in Clinical & Experimental Metastasis
    Article 13 April 2024
  2. Predictive value of CT and 18F-FDG PET/CT features on spread through air space in lung adenocarcinoma

    Background

    Lung adenocarcinoma, a leading cause of cancer-related mortality, demands precise prognostic indicators for effective management. The...

    Haijun Li, Lifeng Li, ... Dechang Peng in BMC Cancer
    Article Open access 08 April 2024
  3. FDG-PET/CT-based respiration-gated lung segmentation and quantification of lung inflammation in COPD patients

    Objective and results description

    The study objective was to investigate the potential of quantitative measures of pulmonary inflammation by...

    Ayse Dudu Altintas Dogan, Thomas Quist Christensen, ... Søren Hess in BMC Research Notes
    Article Open access 20 June 2024
  4. Comparison of whole-body 18F-FDG PET/CT and PET/MRI for distant metastases in patients with malignant tumors: a meta-analysis

    Background

    As a first-line imaging modality, whole-body fluorine-18 fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed...

    Cici Zhang, Zhishan Liang, ... Yuzhen Mo in BMC Cancer
    Article Open access 10 January 2023
  5. Automated detection, delineation and quantification of whole-body bone metastasis using FDG-PET/CT images

    Non-small cell lung cancer (NSCLC) patients with the metastatic spread of disease to the bone have high morbidity and mortality. Stereotactic...

    R. Nigam, M. Field, ... L. Holloway in Physical and Engineering Sciences in Medicine
    Article Open access 01 May 2023
  6. [18F]FDG PET/CT Imaging in Cancer Treatment with Checkpoint Inhibitors

    In the last decade, the development of new therapeutic agents modulating the activity of the immune system and boosting its response against cancer...
    Barbara Catalfamo, Egesta Lopci in Handbook of Cancer and Immunology
    Living reference work entry 2023
  7. Prognostic value of pre-treatment [18F] FDG PET/CT in recurrent nasopharyngeal carcinoma without distant metastasis

    Background

    [18 F]-Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) has the ability to detect local and/or regional...

    Zhe Dong, Gao-Yuan Wang, ... Jun Ma in BMC Cancer
    Article Open access 15 April 2024
  8. [18F]FDG-PET/CT-based risk stratification in women with locally advanced uterine cervical cancer

    Background

    [ 18 F]FDG-PET/CT is used for staging and treatment planning in patients with locally advanced cervical cancer (LACC). We studied if a...

    J.A. Adam, E. Poel, ... S. Bipat in BMC Cancer
    Article Open access 23 April 2024
  9. PET/CT in assessment of colorectal liver metastases: a comprehensive review with emphasis on 18F-FDG

    Approximately 25% of those who are diagnosed with colorectal cancer will develop colorectal liver metastases (CRLM) as their illness advances....

    Mahdi Zirakchian Zadeh in Clinical & Experimental Metastasis
    Article 08 September 2023
  10. Prediction of the axillary lymph-node metastatic burden of breast cancer by 18F-FDG PET/CT-based radiomics

    Background

    The axillary lymph-node metastatic burden is closely associated with treatment decisions and prognosis in breast cancer patients. This...

    Yan Li, Dong Han, Cong Shen in BMC Cancer
    Article Open access 07 June 2024
  11. Deciphering the correlation between metabolic activity through 18F-FDG-PET/CT and immune landscape in soft-tissue sarcomas: an insight from the NEOSARCOMICS study

    Metabolic elevation in soft-tissue sarcomas (STS), as documented with 18 F-Fluorodeoxyglucose positron emission tomography ( 18 F-FDG-PET/CT) has been...

    Amandine Crombé, Frédéric Bertolo, ... Antoine Italiano in Biomarker Research
    Article Open access 07 January 2024
  12. Non-calcified active atherosclerosis plaque detection with 18F-NaF and 18F-FDG PET/CT dynamic imaging

    Arterial inflammation is an indicator of atheromatous plaque vulnerability to detach and to obstruct blood vessels in the heart or in the brain thus...

    Abdelillah Douhi, Mamdouh S. Al‑enezi, ... M’hamed Bentourkia in Physical and Engineering Sciences in Medicine
    Article 30 January 2023
  13. Survival time prediction in patients with high-grade serous ovarian cancer based on 18F-FDG PET/CT- derived inter-tumor heterogeneity metrics

    Background

    The presence of heterogeneity is a significant attribute within the context of ovarian cancer. This study aimed to assess the predictive...

    Dianning He, **n Zhang, ... Beibei Li in BMC Cancer
    Article Open access 12 March 2024
  14. Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT

    Background

    We compared overall survival for metastatic breast cancer (MBC) patients monitored with CE-CT, FDG-PET/CT or a combination of them in an...

    Mohammad Naghavi-Behzad, Marianne Vogsen, ... Malene Grubbe Hildebrandt in British Journal of Cancer
    Article 10 January 2022
  15. Development and validation of a 18F-FDG PET/CT radiomics nomogram for predicting progression free survival in locally advanced cervical cancer: a retrospective multicenter study

    Background

    The existing staging system cannot meet the needs of accurate survival prediction. Accurate survival prediction for locally advanced...

    Huiling Liu, Yongbin Cui, ... Ruozheng Wang in BMC Cancer
    Article Open access 30 January 2024
  16. Associations between detectable circulating tumor DNA and tumor glucose uptake measured by 18F-FDG PET/CT in early-stage non-small cell lung cancer

    Background

    The low level of circulating tumor DNA (ctDNA) in the blood is a well-known challenge for the application of liquid biopsies in early-stage...

    Anine Larsen Ottestad, Håkon Johansen, ... Bjørn Henning Grønberg in BMC Cancer
    Article Open access 11 July 2023
  17. Prognostic value of baseline 18F-FDG PET/CT in patients with esophageal squamous cell carcinoma treated with definitive (chemo)radiotherapy

    Purpose

    To investigate the prognostic value of baseline 18 F-FDG PET/CT in patients with esophageal squamous cell carcinoma (ESCC) treated with...

    Lianshuang **a, **aoxu Li, ... Zhenguang Wang in Radiation Oncology
    Article Open access 24 February 2023
  18. High expression of HNRNPR in ESCA combined with 18F-FDG PET/CT metabolic parameters are novel biomarkers for preoperative diagnosis of ESCA

    Background

    The aim of this study was to determine the expression and function of heterogeneous nuclear ribonucleoprotein R (HNRNPR) in esophageal...

    **ao-Yu Liu, Yan Gao, ... Zhi-Jun Pei in Journal of Translational Medicine
    Article Open access 04 October 2022
  19. Retrospective analysis of the 18F-FDG PET/CT cutoff value for metabolic parameters was performed as a prediction model to evaluate risk factors for endometrial cancer

    Purpose

    The study retrospectively analyzed the accuracy and predictive ability of preoperative integrated whole-body 18 F-FDG PET/CT for the...

    Ye Yang, Yu-Qin Pan, ... Wei Bao in Radiation Oncology
    Article Open access 04 December 2023
  20. Condition control training-based ConVMLP-ResU-Net for semantic segmentation of esophageal cancer in 18F-FDG PET/CT images

    The precise delineation of esophageal gross tumor volume (GTV) on medical images can promote the radiotherapy effect of esophagus cancer. This work...

    Yaoting Yue, Nan Li, ... Dean Ta in Physical and Engineering Sciences in Medicine
    Article 01 November 2023
Did you find what you were looking for? Share feedback.